Ouro Fino Saude Animal Participacoes SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ouro Fino Saude Animal Participacoes SA with three other
pharmaceutical manufacturers in Latin America:
Genomma Lab Internacional Sab De Cv
of Mexico
(2017
sales of 12.08 billion Mexican Pesos [US$667.70 million]
),
Instituto Hermes Pardini SA
(1.12 billion Brazilian Reals [US$330.49 million]
of which 55%
was Reference Labs), and
Fleury SA
(2.38 billion Brazilian Reals [US$705.04 million]
of which 84%
was Diagnostic Medicine).
Sales Analysis.
During the year ended December of 2017, sales at
Ouro Fino Saude Animal Participacoes SA were 505.28 million Brazilian Reals (US$149.49 million).
This
is
an
increase of 10.7%
versus 2016, when the company's sales were 456.59 million Brazilian Reals.
Despite this increase, sales are still
below the level achieved in 2015, when Ouro Fino Saude Animal Participacoes SA
reported sales of 534.05 million Brazilian Reals.
Sales of Pets saw an increase
of
11.8% in 2017, from
54.50 million Brazilian Reals to 60.94 million Brazilian Reals.